GENE ONLINE|News &
Opinion
Blog

Migraine
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Weekly Top 5 in China (0210-0216)
2019-02-18
Clash of three migraines medications & cost benefit for patients
2018-10-01
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
LATEST
From Fabs to Labs: TSMC, Mayo Clinic, and the Next Wave of Bio-Digital Innovation in Phoenix
2025-07-17
AI-Powered Wound Care: 3D Digital TwinSkin Tech from Belgium to Asia
2025-07-16
XTANDI Plus Leuprolide Boosts Survival in Men at Risk of Prostate Cancer Relapse
2025-07-16
A Billion-Year Gap Closed With Lunar Meteorite Rewriting History
2025-07-16
A New Contender Rises: China’s Hengrui and Innovent Challenge Zepbound and Wegovy in Global Weight-Loss Drug Race
2025-07-16
Indian Kirana Stores Offer Trust-Building Lessons for the $638 Billion Global Pharmaceutical Industry
2025-07-16
Biotin Gummies Gain Popularity on Social Media Amid Debates Over Hair Growth Claims
2025-07-15
EVENT
2025-07-23
BIO Asia–Taiwan 2025
Taipei, Taiwan
2025-08-08
HEALTHY AGEING TECH SHOW
Taipei, Taiwan
2025-08-09
MEDINFO 2025
Taipei, Taiwan
2025-09-03
BIO ASIA PACIFIC 2025
Bangkok, Thailand
2025-09-10
BIOHK 2025
Hong Kong
2025-10-01
Medical Japan 2025
Osaka, Japan
Scroll to Top